GlassScriptPhysician profile
Gon E Saman
NPI 1588223002
$6,481.81
in general payments reported to CMS, 2019-2025
9 companies · $3,254 in 2025
The $3,254 reported for 2025 was more than what 90% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,817 · 2023: $186 · 2024: $1,225 · 2025: $3,254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,940 · Consulting Fee: $1,700 · Travel and Lodging: $25.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,939.95 |
| Consulting Fee | $1,700.00 |
| Travel and Lodging | $25.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,875.67 | 2024-2025 | Via Matrix, Nushield, Simplimax |
| Treace Medical Concepts, INC. | $1,587.43 | 2024-2025 | |
| Arthrex, INC. | $1,200.00 | 2021 | |
| Orthofix Medical, INC. | $322.89 | 2021 | |
| Integra Lifesciences Corporation | $186.16 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Linvatec Corporation | $141.68 | 2021 | |
| Depuy Synthes Sales INC. | $128.17 | 2021 | |
| Mvp Orthopedics INC | $23.92 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.89 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gon Saman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.